Close Menu

Novartis, Caliper, VisEn

Premium
Novartis Licenses Caliper’s Non-Invasive Optical Imaging Methods
 
Caliper Life Sciences this week announced that Novartis has signed a multi-year license to Caliper's patented non-invasive optical imaging methods.
 
Caliper said that it has placed over 450 of its Xenogen IVIS units to date and recently launched the new Xenogen IVIS Spectrum system.
 

 
VisEn Asks USPTO to Invalidate Caliper's In Vivo Imaging Patent
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.